A 78-year-old white American man presented with fever, jaundice, and respiratory distress. Laboratory tests showed the following: white blood cells 4.2 (4-11) × 109/L, hemoglobin 11.7 (13.1-17.2) g/dL, platelets 21 (140-440) × 109/L, bilirubin 9.2 (0.2-1.2) mg/dL, aspartate aminotransferase 1345 (10-37) U/L, alanine aminotransferase 599 (5-40) U/L, alkaline phosphatase 313 (40-125) U/L, lactate dehydrogenase 2102 (98-192) U/L, international normalized ratio 2.4 (0.89-1.29), activated partial thromboplastin time 149 (22-36) seconds, haptoglobin <20 (30-200) mg/dL, and fibrinogen 56 (200-425) mg/dL. A chest–computed tomography scan revealed pulmonary infiltrates and mediastinal lymphadenopathy. Subcarinal lymph node biopsy showed numerous small-to-medium neoplastic cells (panel A) that expressed CD2, cCD3 (panel B), CD7, CD30, CD56 (panel C), TIA1, granzyme B, perforin, and Epstein-Barr virus (EBV; panel D) and were negative for CD4, CD5, and CD8. The Ki67 proliferation index on this specimen showed 90% nuclear staining. Peripheral blood flow cytometry showed 17% abnormal natural killer cells (panel E) expressing CD2, CD7dim, TIA1, and CD56dim and was negative for sCD3 and terminal deoxynucleotidyl transferase. A diagnosis of EBV-associated aggressive natural killer cell leukemia (ANKL) was established. The patient deteriorated rapidly and died.
ANKL is a rare, aggressive, EBV-associated leukemia primarily affecting young Asians. B symptoms, organomegaly, hemophagocytosis, and disseminated intravascular coagulation are common. Complex cytogenetic abnormalities are relatively frequent, and clonal T-cell receptor gene rearrangements are absent. ANKL has been reported in fewer than 20 patients of white Western European descent.
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal